Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Keep Your Eye On The Ball - Watch List -- Ignore unavailable to you. Want to Upgrade?

To: TFF who wrote (1696)	2/13/2000 2:42:00 PM
From: scaram(o)uche	Respond to of 2802

Biotech.... relative or absolute "value" has not necessarily been the place to be, but.... I would suggest that these issues, among those you listed, are absolute or relative bargains..... BTRN GLIA GZMO KDUS NBIX NRGN OSIP SEPR Everyone will have their own list, and, again, "value" hasn't been the best place to be. KDUS is a special little situation.... almost no float. You could purchase the entire float for $3.6 million at Friday's closing ask, market value to book is only two, and "pop potential" can be had from several widely diverse angles. Very nice list, thanks! Would suggest adding CTII.